Versant Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.38K	Buy	+154	New	+$1.38K	﹤0.01%	2448
2023 Q3	–	Sell	-59	Closed	-$415	–	1948
2023 Q2	$415	Buy	+59	New	+$415	﹤0.01%	1873